Oncologists should take advantage of the best guidance available from the research that’s being conducted by the industry and by other clinicians.
That should feature all the relevant outcomes. It should take into account the issues related to patient benefits, quality of life, and relevant information about the service impact, and the even wider societal benefit in sort of a value‑based assessment approach.
